J R Lindsay1, V K Shanmugam, E H Oldfield, A T Remaley, L K Nieman. 1. Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda MD 20892-1109, USA.
Abstract
OBJECTIVE: Measurement of plasma ACTH levels by radioimmunoassay (RIA) is used to identify adrenal causes (AA) of Cushing's syndrome (CS) and to distinguish ectopic CS (EAS) from Cushing's disease (CD) using CRH stimulation testing and inferior petrosal sinus sampling (IPSS). We wished to determine whether diagnostic criteria developed with RIA would also be applicable for immunoradiometric (IRMA) or immunochemiluminescent (ICMA) assays. SUBJECTS AND METHODS: ACTH was measured by RIA, immunoradiometric and/or immunochemiluminescent assay on samples obtained during three types of diagnostic testing in a tertiary referral setting: a) basally (63 CD, 5 AA, 2 EAS and 37 non-CS patients); b) in 44 CD patients following CRH; c) in 6 ectopic CS and 17 CD patients during IPSS. The primary outcome was comparison of diagnostic utility. RESULTS: a) IRMA results, while lower, correlated highly with RIA (r=0.9, p<0.0001) and had similar sensitivity (100 vs 80%) and specificity (89 vs 94%) for the diagnosis of AA (p=0.3); b) the sensitivity for CD of CRH testing using IRMA was similar to that of RIA (85 vs 83%, p=1.0); c) during IPSS, IRMA had similar sensitivity (100%) and specificity (100 vs 83%) compared with ICMA or RIA (p=1.0). CONCLUSIONS: ACTH immunometric assays correlate closely to RIA and offer similar diagnostic utility.
OBJECTIVE: Measurement of plasma ACTH levels by radioimmunoassay (RIA) is used to identify adrenal causes (AA) of Cushing's syndrome (CS) and to distinguish ectopic CS (EAS) from Cushing's disease (CD) using CRH stimulation testing and inferior petrosal sinus sampling (IPSS). We wished to determine whether diagnostic criteria developed with RIA would also be applicable for immunoradiometric (IRMA) or immunochemiluminescent (ICMA) assays. SUBJECTS AND METHODS: ACTH was measured by RIA, immunoradiometric and/or immunochemiluminescent assay on samples obtained during three types of diagnostic testing in a tertiary referral setting: a) basally (63 CD, 5 AA, 2 EAS and 37 non-CS patients); b) in 44 CDpatients following CRH; c) in 6 ectopic CS and 17 CDpatients during IPSS. The primary outcome was comparison of diagnostic utility. RESULTS: a) IRMA results, while lower, correlated highly with RIA (r=0.9, p<0.0001) and had similar sensitivity (100 vs 80%) and specificity (89 vs 94%) for the diagnosis of AA (p=0.3); b) the sensitivity for CD of CRH testing using IRMA was similar to that of RIA (85 vs 83%, p=1.0); c) during IPSS, IRMA had similar sensitivity (100%) and specificity (100 vs 83%) compared with ICMA or RIA (p=1.0). CONCLUSIONS:ACTH immunometric assays correlate closely to RIA and offer similar diagnostic utility.
Authors: G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro Journal: J Clin Endocrinol Metab Date: 2003-12 Impact factor: 5.958
Authors: E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux Journal: N Engl J Med Date: 1991-09-26 Impact factor: 91.245
Authors: P M Stewart; S Gibson; S R Crosby; R Penn; R Holder; D Ferry; N Thatcher; P Phillips; D R London; A White Journal: Clin Endocrinol (Oxf) Date: 1994-02 Impact factor: 3.478
Authors: John R Lindsay; Edward H Oldfield; Constantine A Stratakis; Lynnette K Nieman Journal: J Clin Endocrinol Metab Date: 2011-04-20 Impact factor: 5.958
Authors: Nicola M Neary; O Julian Booker; Brent S Abel; Jatin R Matta; Nancy Muldoon; Ninet Sinaii; Roderic I Pettigrew; Lynnette K Nieman; Ahmed M Gharib Journal: J Clin Endocrinol Metab Date: 2013-04-04 Impact factor: 5.958
Authors: Joshua J Wind; Russell R Lonser; Lynnette K Nieman; Hetty L DeVroom; Richard Chang; Edward H Oldfield Journal: J Clin Endocrinol Metab Date: 2013-04-03 Impact factor: 5.958
Authors: Ben Gibbison; Daniel M Keenan; Ferdinand Roelfsema; Jon Evans; Kirsty Phillips; Chris A Rogers; Gianni D Angelini; Stafford L Lightman Journal: J Clin Endocrinol Metab Date: 2020-05-01 Impact factor: 5.958
Authors: Igor O Nasonkin; Robert D Ward; David L Bavers; Felix Beuschlein; Amanda H Mortensen; Catherine E Keegan; Gary D Hammer; Sally A Camper Journal: PLoS One Date: 2011-12-01 Impact factor: 3.240
Authors: O Polat Korkmaz; B Karayel; M Korkmaz; O Haliloglu; S Sahin; E Durcan; M M Oren; P Kadioglu Journal: Acta Endocrinol (Buchar) Date: 2019 Apr-Jun Impact factor: 0.877